The NOD mouse: A model of immune dysregulation

被引:854
作者
Anderson, MS [1 ]
Bluestone, JA [1 ]
机构
[1] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA
关键词
autoimmunity; T lymphocytes; animal models; type; 1; diabetes; immunotherapy; tolerance;
D O I
10.1146/annurev.immunol.23.021704.115643
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoimmunity is a complex process that likely results from the summation of multiple defective tolerance mechanisms. The NOD mouse strain is an excellent model of autoimmune disease and an important tool for dissecting tolerance mechanisms. The strength of this mouse strain is that it develops spontaneous autoimmune diabetes, which shares many similarities to autoimmune or type 1a diabetes (T1D) in human subjects, including the presence of pancreas-specific autoantibodies, autoreactive CD4(+) and CD8(+) T cells, and genetic linkage to disease syntenic to that found in humans. During the past ten years, investigators have used a wide variety of tools to study these mice, including immunological reagents and transgenic and knockout strains; these tools have tremendously enhanced the study of the fundamental disease mechanisms. In addition, investigators have recently developed a number of therapeutic interventions in this animal model that have now been translated into human therapies. In this review, we summarize many of the important features of disease development and progression in the NOD strain, emphasizing the role of central and peripheral tolerance mechanisms that affect diabetes in these mice. The information gained from this highly relevant model of human disease will lead to potential therapies that may alter the development of the disease and its progression in patients with T1D.
引用
收藏
页码:447 / 485
页数:39
相关论文
共 236 条
[11]   The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice [J].
Ansari, MJI ;
Salama, AD ;
Chitnis, T ;
Smith, RN ;
Yagita, H ;
Akiba, H ;
Yamazaki, T ;
Azuma, M ;
Iwai, H ;
Khoury, SJ ;
Auchincloss, H ;
Sayegh, MH .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) :63-69
[12]   In vivo instruction of suppressor commitment in naive T cells [J].
Apostolou, I ;
von Boehmer, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (10) :1401-1408
[13]   Origin of regulatory T cells with known specificity for antigen [J].
Apostolou, I ;
Sarukhan, A ;
Klein, L ;
von Boehmer, H .
NATURE IMMUNOLOGY, 2002, 3 (08) :756-763
[14]   Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism [J].
Arreaza, GA ;
Cameron, MJ ;
Jaramillo, A ;
Gill, BM ;
Hardy, D ;
Laupland, KB ;
Rapoport, MJ ;
Zucker, P ;
Chakrabarti, S ;
Chensue, SW ;
Qin, HY ;
Singh, B ;
Delovitch, TL .
JOURNAL OF CLINICAL INVESTIGATION, 1997, 100 (09) :2243-2253
[15]   Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation [J].
Asano, M ;
Toda, M ;
Sakaguchi, N ;
Sakaguchi, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :387-396
[16]   The NOD mouse model of type 1 diabetes: As good as it gets? [J].
Atkinson, MA ;
Leiter, EH .
NATURE MEDICINE, 1999, 5 (06) :601-604
[17]   Fatal attraction: chemokines, and type 1 diabetes [J].
Atkinson, MA ;
Wilson, SB .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 110 (11) :1611-1613
[18]   Disorganization of thymic medulla precedes evolution towards diabetes in female NOD mice [J].
Atlan-Gepner, C ;
Naspetti, M ;
Valéro, R ;
Barad, M ;
Lepault, F ;
Vialettes, B ;
Naquet, P .
AUTOIMMUNITY, 1999, 31 (04) :249-260
[19]   INSULIN-DEPENDENT DIABETES-MELLITUS AS AN AUTOIMMUNE-DISEASE [J].
BACH, JF .
ENDOCRINE REVIEWS, 1994, 15 (04) :516-542
[20]   Mechanisms of disease: The effect of infections on susceptibility to autoimmune and allergic diseases [J].
Bach, JF .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (12) :911-920